Skip to main content
CVS logo

CVS Health Corp. (CVS) Stock: Price, Forecast & Analyst Target

CVS Health Corp. (CVS) — MoonshotScore 81/100 (Exceptional band), calculated Nov 18, 2026. Price $80.06 (-1.59%), as of the Nov 19, 2026 trading session; market cap $102B. Expected results Feb 9, 2027.

Educational signal · not a buy or sell recommendation · How to read this

$80.06 −$1.29 (-1.59%) Market Cap $102B

CVS Health Corp. · CVS · NYSE · Healthcare · Medical - Healthcare Plans

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services.

Price as of Nov 19, 2026

Key Statistics

81 of 100

MoonshotScore v2 · CVS Health (CVS)

Exceptional
Business Quality Solid (72)
Financial Safety Strained (38)
Valuation Cheap (90)
Growth Durability Compounding (90)
Momentum Rising (71)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality and elite growth, at a dirt-cheap price, but a strained balance sheet; the market is already moving on it. Business Quality: Solid; Financial Safety: Strained; Valuation: Cheap; Growth Durability: Compounding; Momentum: Rising.

  • quarterly revenue $108.40B (Q3 FY2026, quarter ended Sep 2026)
  • EPS beat 8 of the last 8 reports
  • expected results Feb 9, 2027

Helping: business quality, an attractive price, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for CVS (57 recorded, newest six shown)
RecordedScoreBand
75Strong
75Strong
75Strong
75Strong
81Exceptional
81Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$80.06
Change on the day-1.59%
52-week range$69.51–$110.68
Market capitalisation$102B—
Price / earnings (trailing)9.91
Shares traded on the day12.47M
Beta (volatility vs the S&P 500)0.58

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $70, high $108, latest $80. 4 reported quarters marked, 4 above and 0 below the recorded estimate. $108 $70 high $108 Feb 10, 2026 · Earnings results · reported above the recorded estimate · close $781May 6, 2026 · Earnings results · reported above the recorded estimate · close $912Aug 5, 2026 · Earnings results · reported above the recorded estimate · close $963Nov 4, 2026 · Earnings results · reported above the recorded estimate · close $844 Oct 17, 2025 Nov 19, 2026 · $80 $83Oct 17, 2025$78Oct 31, 2025$78Nov 14, 2025$80Nov 28, 2025$79Dec 12, 2025$80Dec 26, 2025$80Jan 9, 2026$83Jan 23, 2026$78Feb 6, 2026$77Feb 20, 2026$78Mar 6, 2026$71Mar 20, 2026$73Apr 2, 2026$77Apr 17, 2026$82May 1, 2026$96May 15, 2026$91May 29, 2026$102Jun 12, 2026$104Jun 26, 2026$104Jul 10, 2026$108Jul 24, 2026$96Aug 7, 2026$93Aug 21, 2026$97Sep 4, 2026$89Sep 18, 2026$86Oct 2, 2026$92Oct 16, 2026$90Oct 30, 2026$89Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate
How to read these dates

Estimated dates can change.

What to watch next

Other perspectives

Council score for CVS Health (CVS): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Weak
Valuation Strong
Growth Durability Strong
Momentum Moderate

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Neutral read

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Undervalued
Profit Margin Weak
Revenue Growth Neutral
Debt/Equity Weak
ROE Moderate
Gross Margin Weak

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 18, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is CVS Health (CVS), and what does it report?

Short answer

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. CVS Health Corp. (CVS) is listed on NYSE. Healthcare / Medical Healthcare Plans SEC filing business address: ONE CVS DR., Woonsocket, RI, 02895. It employs 259,500 people and is led by J. David Joyner. In Q3 FY2026 it reported revenue of $108.40B and net income of $2.17B. The market values it at $102B.

2 · Latest results

What do the latest results show for CVS Health (CVS)?

Short answer · as of

The most recent reported quarter, Q3 FY2026, carried revenue of $108.40B. Against analyst estimates the company has EPS beat 8 of the last 8 reports.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$108.40B Nov 4, 2026
Latest report · revenue estimate
$104.72B Nov 4, 2026
Latest report · revenue vs estimate
Above estimate Nov 4, 2026
Latest report · EPS vs estimate
Above estimate Nov 4, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Nov 4, 2026$108.40B$104.72B$2.0900$1.6500
Aug 5, 2026$106.10B$100.03B$2.5800$1.8500
May 6, 2026$100.43B$94.99B$2.5700$2.1800
Feb 10, 2026$105.69B$103.70B$1.0900$1.0000
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2026$108.40B$2.17B$1.68 (diluted)
Q2 FY2026$106.10B$3.00B$2.33 (diluted)
Q1 FY2026$100.43B$2.94B$2.30 (diluted)
Q4 FY2025$105.69B$2.94B$2.30 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for CVS Health (CVS)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway. The MoonshotScore pillars rate business quality, an attractive price, durable growth, positive momentum as strengths. The distress and quality screens read Altman Z 2.50 · Piotroski F 8. Trailing ratios: ROE 14.4% · ROA 3.1% · current ratio 0.85.

4 · What to check next?

What should you watch next at CVS Health (CVS)?

Short answer · as of

The next earnings report is expected on Feb 9, 2027. Current published price targets run low $103.00 · high $123.00 · consensus $110.56 · median $110.50 against a quoted price of $80.06 (as of Nov 19, 2026).

5 · Peer comparison

How does CVS Health compare with its peers?

Short answer

CVS Health's score ranks tied for 7th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Oscar Health, Inc. (OSCR) Same industry, near in market value$27.57 Nov 18, 2026$8.57B97 5-pillar Nov 18, 2026
Clover Health Investments, Corp. (CLOV) Same industry, near in market value$4.17 Nov 18, 2026$2.23B94 5-pillar Nov 18, 2026
Centene Corporation (CNC) Same industry, near in market value$65.62 Nov 19, 2026$32.5B91 5-pillar Nov 18, 2026
Vertex Pharmaceuticals Incorporated (VRTX) Named competitor$536.45 Nov 18, 2026$136B90 5-pillar Nov 18, 2026
Elevance Health Inc. (ELV) Same industry, near in market value$400.84 Nov 18, 2026$86.6B88 5-pillar Nov 18, 2026
Bristol-Myers Squibb Company (BMY) Named competitor$59.56 Nov 18, 2026$122B85 5-pillar Nov 18, 2026
CVS Health (CVS) — this page$80.06$102B81
Medtronic plc (MDT) Named competitor$100.72 Nov 18, 2026$129B81 5-pillar Nov 18, 2026
Humana Inc. (HUM) Same industry, near in market value$385.78 Nov 18, 2026$46.3B79 5-pillar Nov 18, 2026
Cigna Corporation (CI) Same industry, near in market value$273.09 Nov 19, 2026$72.0B78 5-pillar Nov 18, 2026
GSK plc (GSK) Named competitor$48.58 Nov 18, 2026$97.4B77 5-pillar Nov 18, 2026
HCA Healthcare, Inc. (HCA) Named competitor$476.35 Nov 18, 2026$99.5B77 5-pillar Nov 18, 2026
UnitedHealth Group Incorporated (UNH) Same industry, near in market value$349.91 Nov 18, 2026$314B76 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$103.00 – $123.00
Consensus target
$110.56
Median target
$110.50

Consensus record · Captured .

Measured against a quoted price of $80.06 (as of Nov 19, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 6, 2026

Transactions
4
Identified insiders
4
Purchases
1
Sales
0
Other transactions
3

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held CVS in their latest 13F filing, and what they did against the filing before it.

InvestorManager13F quarterPortfolio weightValueLast quarter
Bridgewater AssociatesFounded by Ray DalioQ3 20260.14%$32.40MTrimmed −14.2% shares
Viking GlobalAndreas HalvorsenQ3 20260%$0Sold out (was $378.97M)

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

Common Questions About CVS (Healthcare)

These answers are editorial: 1 of these 8 answers is drawn from the CVS research dossier (written May 10, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for CVS?

CVS carries the MoonshotScore stated above — the Exceptional band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is CVS a good stock to buy?

Stock Expert AI does not rate CVS buy, sell or hold. CVS Health Corp. carries a MoonshotScore, in the Exceptional band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the CVS stock price today?

The last price recorded for CVS Health Corp. (CVS), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the CVS price target?

The analyst consensus price target for CVS Health Corp. (CVS), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

What does CVS Health Corporation do?

CVS Health Corporation operates as a diversified healthcare company, providing a wide range of services through its three main segments: Health Care Benefits, Pharmacy Services, and Retail/LTC.

What are the key factors to evaluate for CVS?

CVS Health Corp. (CVS) holds a MoonshotScore in the high range. To weigh it, compare the trailing P/E under Price & valuation with the analyst view under Analyst targets & estimates on this page. Not financial advice.

How frequently does CVS data refresh on this page?

CVS's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven CVS's recent stock price performance?

CVS Health Corp. (CVS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated healthcare model with diverse revenue streams. See the News tab for the latest drivers. Past performance does not predict future results.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 49 figures on this page — 1 from SEC filings and earnings calls, 40 from Financial Modeling Prep (FMP), 5 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.

ETFs that hold CVS

Funds in our ETF coverage that list CVS among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
IHF ETF13.24%
First Trust Nasdaq Retail ETF (FTXD)5.68%
Davis Select U.S. Equity ETF (DUSA)5.00%
Invesco S&P 500 Value with Momentum ETF (SPVM)1.33%
Invesco Global ESG Revenue ETF (ESGF)0.88%